hereditary hemorrhagic telangiectasia hht also known disease syndrome rare autosomal dominant genetic disorder leads abnormal blood vessel formation skin mucous membranes often organs lungs liver may lead nosebleeds acute chronic digestive tract bleeding various problems due involvement organs treatment focuses reducing bleeding blood vessel lesions sometimes surgery targeted interventions remove arteriovenous malformations organs chronic bleeding often requires iron supplements sometimes blood transfusions hht transmitted autosomal dominant fashion occurs one people north disease carries names sir william osler henri jules louis marie rendu frederick parkes weber described late early telangiectasia small vascular malformations may occur skin mucosal linings nose gastrointestinal tract common problem nosebleeds epistaxis happen frequently childhood affect people hht lesions skin mouth bleed less often may considered cosmetically displeasing affect skin lesions characteristically occur lips nose fingers skin face sunexposed areas appear suddenly number increasing affected symptomatic digestive tract lesions although higher percentage lesions cause symptoms lesions may bleed intermittently rarely significant enough noticed form bloody vomiting black stool eventually lead depletion iron body resulting irondeficiency arteriovenous malformations avms larger vascular malformations occur larger organs predominantly lungs pulmonary avms liver brain cerebral avms small proportion avms spinal vascular malformations lungs may cause number problems lungs normally filter bacteria blood clots bloodstream avms bypass capillary network lungs allow migrate brain bacteria may cause brain abscess blood clots may lead hht common cause lung avms people found lung avms due bleeding lung avms relatively unusual may cause hemoptysis coughing blood hemothorax blood accumulating chest large vascular malformations lung allow oxygendepleted blood right ventricle bypass alveoli meaning blood opportunity absorb fresh oxygen may lead large avms may lead platypnea difficulty breathing marked sitting compared lying probably reflects changes blood flow associated large avms cause marked inability absorb oxygen may noted cyanosis bluish discoloration lips skin clubbing fingernails often encountered chronically low oxygen levels humming noise affected part lung detectable symptoms produced avms liver depend type abnormal connection form blood vessels connection arteries veins large amount blood bypasses bodys organs heart compensates increasing cardiac output eventually congestive cardiac failure develops highoutput cardiac failure breathlessness leg swelling among avm creates connection portal vein blood vessels liver result may portal hypertension increased portal vein pressure collateral blood vessels form esophagus esophageal varices may bleed violently furthermore increased pressure may give rise fluid accumulation abdominal cavity ascites flow avm direction portal venous blood flows directly veins rather running liver may lead hepatic encephalopathy confusion due portal waste products irritating brain rarely bile ducts deprived blood leading severe cholangitis inflammation bile liver avms detectable people hht experience problems brain avms occasionally exert pressure leading headaches may also increase risk seizures would abnormal tissue brain finally hemorrhage avm may lead intracerebral hemorrhage bleeding brain causes symptoms stroke weakness part body difficulty speaking bleeding occurs subarachnoid space subarachnoid hemorrhage usually severe sudden headache decreased level consciousness often weakness part small proportion affected mutations see multiple benign polyps large intestine may bleed transform colorectal cancer similarly small proportion experiences pulmonary hypertension state pressure lung arteries increased exerting pressure right side heart causing peripheral edema swelling legs fainting attacks chest pain observed risk thrombosis particularly venous thrombosis form deep vein thrombosis pulmonary embolism may increased suspicion hht may mild immunodeficiency therefore slightly increased risk hht genetic disorder autosomal dominant inheritance pattern hht symptoms relatives disease may new homozygosity appears fatal five genetic types hht recognized three linked particular genes two remaining currently associated particular locus cases hht due mutations either eng total different mutations known likely predominance either type particular populations data conflicting mutations cause colonic polyposis addition hht comprise diseasecausing mutations apart clear whether mutations eng lead particular although reports suggest eng mutations likely cause lung problems mutations may cause liver pulmonary hypertension may particular problem people people exactly mutations may different nature severity symptoms suggesting additional genes risk factors may determine rate lesions develop yet telangiectasias arteriovenous malformations hht thought arise changes angiogenesis development blood vessels existing ones development new blood vessel requires activation migration various types cells chiefly endothelium smooth muscle pericytes exact mechanism hht mutations influence process yet clear likely disrupt balance pro antiangiogenic signals blood vessels wall telangiectasias unusually friable explains tendency lesions genes known far linked hht code proteins tgfÎ² signaling pathway group proteins participates signal transduction hormones transforming growth factor beta superfamily transforming growth factor beta bone morphogenetic protein growth differentiation factor classes specifically hormones enter cell link receptors cell membrane activate proteins eventually influencing cellular behavior number ways cellular survival proliferation increasing number differentiation becoming hormone signal adequately transduced combination proteins needed two two types serinethreoninespecific kinase type membrane receptors endoglin bound hormone type ii receptor proteins phosphorylate transfer phosphate onto type receptor proteins one turn phosphorylate complex smad proteins chiefly bind migrate cell nucleus act transcription factors participate transcription particular genes addition smad pathway membrane receptors also act mapk pathway additional actions behavior endoglin expressed predominantly endothelium perhaps explaining hhtcausing mutations proteins lead predominantly blood vessel eng mutations lead predominantly underproduction related proteins rather misfunctioning diagnostic tests may conducted various reasons firstly tests needed confirm refute diagnosis secondly needed identify potential skin oral cavity telangiectasias visually identifiable physical examination similarly lesions nose may seen endoscopy nasopharynx laryngoscopy severity nosebleeds may quantified objectively using gridlike questionnaire number nosebleed episodes duration digestive tract telangiectasias may identified esophagogastroduodenoscopy endoscopy esophagus stomach first part small intestine procedure typically undertaken anemia marked expected severity nosebleeds evidence severe bleeding vomiting blood black stools number lesions seen endoscopy unexpectedly low remainder small intestine may examined capsule endoscopy patient swallows capsuleshaped device containing miniature camera transmits images digestive tract portable digital identification avms requires detailed medical imaging organs commonly affected lesions avms cause symptoms risk hence degree variation specialists whether investigations would performed modality often decisions issue reached together lung avms may suspected abnormal appearance lungs chest xray hypoxia low oxygen levels pulse oximetry arterial blood gas determination bubble contrast echocardiography bubble echo may used screening tool identify abnormal connections lung arteries veins involves injection agitated saline vein followed ultrasoundbased imaging heart normally lungs remove small air bubbles circulation therefore seen right atrium right ventricle avm present bubbles appear left atrium left ventricle usually cardiac cycles right side slower heart defects direct connections right left side heart larger number bubbles likely indicate presence avm bubble echo perfect screening tool miss smaller avms identify site avms often contrastenhanced computed tomography ct angiography used identify lung lesions modality sensitivity may possible omit contrast administration modern ct echocardiography also used suspicion pulmonary hypertension highoutput cardiac failure due large liver lesions sometimes followed cardiac catheterization measure pressures inside various chambers liver avms may suspected abnormal liver function tests blood symptoms heart failure develop jaundice symptoms liver dysfunction reliable initial screening test doppler ultrasonography liver high sensitivity identifying vascular lesions liver necessary contrastenhanced ct may used characterize extremely common find incidental nodules liver scans commonly due focal nodular hyperplasia fnh hundredfold times common hht compared general population fnh regarded harmless generally tumor markers additional imaging modalities used differentiate fnh malignant tumors liver liver biopsy discouraged people hht risk hemorrhage liver avms may liver scans may useful someone suspected hht meet criteria see unless liver lesions brain avms may detected computed tomography angiography cta ct angio magnetic resonance angiography mra cta better showing vessels mra provides detail relationship avm surrounding brain general mri various types vascular malformations may encountered avms microavms telangiectasias arteriovenous surgery embolization treatment contemplated see cerebral angiography may required get sufficient detail vessels procedure carries small risk stroke therefore limited specific recent professional guidelines recommend children suspected definite hht undergo brain mri early life identify avms cause major others suggest screening cerebral avms probably unnecessary experiencing neurological symptoms lesions discovered screening scans would require treatment creating undesirable genetic tests available eng mutations testing always needed diagnosis symptoms sufficient distinguish disease diagnoses situations testing particularly useful firstly children young adults parent definite hht may limited symptoms yet risk complications mentioned mutation known affected parent absence mutation child would prevent need screening tests furthermore genetic testing may confirm diagnosis limited symptoms otherwise would labeled possible hht see genetic diagnosis hht difficult mutations occur numerous different locations linked genes without particular mutations highly frequent opposed instance mutation cystic fibrosis sequence analysis involved genes therefore useful approach sensitivity followed additional testing detect large deletions duplications additional mutations genes linked mutations gene usually associated juvenile polyposis detection mutation would indicate need screen patient affected relatives polyps tumors large diagnosis made depending presence four criteria known curaÃ§ao three four met patient definite hht two gives possible hht despite designation possible someone visceral avm family history nosebleeds telangiectasias still extremely likely hht avms uncommon general population time said nosebleeds sparse telangiectasias occur people without hht absence avms someones diagnostic status may change course life young children may yet exhibit symptoms age thirteen percent still indeterminate age vast majority definite diagnostic classification children established hht patients may therefore labeled possible hht may turn hht course treatment hht symptomatic deals symptoms rather disease therapy stops development telangiectasias avms directly furthermore treatments applied prevent development common chronic nosebleeds digestive tract bleeding lead anemia bleeding completely stopped anemia requires treatment iron supplements tolerate iron tablets solutions may require administration intravenous iron blood transfusion anemia causing severe symptoms warrant rapid improvement blood treatments used hht described adults experience treating children women hht get pregnant increased risk complications observed closely although absolute risk still low acute nosebleed may managed variety measures packing nasal cavity absorbent swabs gels removal packs bleeding may lead reopening fragile vessels therefore lubricated atraumatic packing patients may wish learn packing deal nosebleeds without resort medical frequent nosebleeds prevented part keeping nostrils moist applying saline solution estrogencontaining creams tranexamic acid side effects may small degree number additional modalities used prevent recurrent bleeding simple measures unsuccessful medical therapies include oral tranexamic acid estrogen evidence relatively limited estrogen poorly tolerated men possibly carries risks cancer heart disease women past nasal coagulation cauterization may reduce bleeding telangiectasias recommended surgery considered however highly recommended use least heat time prevent septal perforations excessive trauma nasal mucosa already susceptible bleedingcitation needed sclerotherapy another option manage bleeding process involves injecting small amount aerated irritant detergent sodium tetradecyl sulfate directly telangiectasias detergent causes vessel collapse harden resulting scar tissue residue procedure used treat varicose veins similar disorderscitation needed may possible embolize vascular lesions interventional radiology requires passing catheter large artery locating maxillary artery xray guidance followed injection vessel particles occlude blood vessels benefit procedure tends may appropriate episodes severe effectively minimize recurrence severity epistaxis options may used conjunction therapies listed intravenously administered antivegf substances bevacizumab brand name avastin pazopinab thalidomide derivatives interfere production new blood vessels weak therefore prone bleeding due past experiences prescribing thalidomide pregnant women alleviate symptoms nausea terrible birth defects followed thalidomide last resort therapy additionally thalidomide cause neuropathy though mitigated tinkering dosages prescribing derivatives lenolidomide pomalidomide many doctors prefer alternative vegf inhibitors bevacizumab shown significantly reduce severity epistaxis without side effectscitation needed interventions failed several operations reported provide benefit one septal dermoplasty saunders skin transplanted nostrils youngs nostrils sealed skin lesions hht disfiguring may respond treatment longpulsed ndyag skin lesions fingertips may sometimes bleed cause pain skin grafting occasionally needed treat regards digestive tract lesions mild bleeding mild resultant anemia treated iron supplementation specific treatment administered limited data hormone treatment tranexamic acid reduce bleeding anemia severe anemia episodes severe bleeding treated endoscopic argon plasma coagulation apc laser treatment lesions identified may reduce need supportive treatment expected benefits repeated attempts treating lesions sudden severe bleeding encountered alternative causes peptic ulcer need embolization may used lung lesions identified usually treated prevent episodes bleeding importantly embolism brain particularly done lesions feeding blood vessel mm larger likely cause longterm complications unless treated effective current therapy embolization detachable metal coils procedure involves puncture large vein usually general anesthetic followed advancing catheter right ventricle pulmonary artery radiocontrast injected visualize avms pulmonary angiography lesion identified coils deployed obstruct blood flow allow lesion regress experienced hands procedure tends effective limited side effects lesions may recur attempts may required cta scans repeated monitor surgical excision essentially abandoned due success either definite pulmonary avms abnormal contrast echocardiogram clearly visible lesions deemed risk brain emboli therefore counselled avoid scuba diving small air bubbles may form bloodstream may migrate brain cause stroke similarly antimicrobial prophylaxis advised procedures bacteria may enter bloodstream dental work avoidance air bubbles intravenous given liver avms generally cause highoutput cardiac failure emphasis treating diuretics reduce circulating blood volume restriction salt fluid intake antiarrhythmic agents case irregular heart beat may sufficient treating symptoms swelling breathlessness treatment effective leads side effects complications remaining option liver transplantation reserved severe symptoms carries mortality leads good results exact point liver transplantion offered yet completely embolization treatment attempted leads severe complications proportion patients liverrelated complications portal hypertension esophageal varices ascites hepatic encephalopathy treated modalities used cirrhosis although use transjugular intrahepatic portosystemic shunt treatment discouraged due lack documented decision treat brain arteriovenous malformations depends symptoms cause seizures headaches bleeding risk predicted previous episodes hemorrhage whether cta mra scan avm appears deepseated deep venous drainage size avm presence aneurysms appears matter hht lesions highflow arteriovenous fistulae tend cause problems treatment warranted avms may regress time without various modalities available depending location avm size surgery radiationbased treatment embolization sometimes multiple modalities used surgery craniotomy open brain surgery may offered based risks treatment determined scale grade iv score higher larger lesions close important brain structures deep venous drainage high grade lesions iv v unacceptably high risk surgery typically offered cases radiosurgery using targeted radiation therapy gamma knife may used lesion small close vital structures finally embolization may used small lesions single feeding several antiangiogenesis drugs approved conditions cancer investigated small clinical antivegf antibody bevacizumab instance used offlabel several studies large clinical trial bevacizumab infusion associated decrease cardiac output reduced duration number episodes epistaxis treated hht thalidomide another antiangiogenesis drug also reported beneficial effects hht thalidomide treatment found induce vessel maturation experimental mouse model hht reduce severity frequency nosebleeds majority small group hht patients blood hemoglobin levels treated patients rose result reduced hemorrhage enhanced blood vessel population studies numerous areas world shown hht occurs roughly rate almost populations somewhere around areas much common instance french region haut jura rate twice common populations attributed founder effect population descending small number ancestors high rate particular genetic trait one ancestors harbored haut jura shown result particular mutation named highest rate hht reported bonaire curaÃ§ao two islands caribbean belonging netherlands people hht normal skin lesions nosebleeds tend develop childhood avms probably present birth dont necessarily cause symptoms frequent nosebleeds common symptom significantly affect quality several century english physicians starting henry gawen sutton followed benjamin guy babington john wickham legg described common features hht particularly recurrent nosebleeds hereditary nature disease french physician henri jules louis marie rendu observed skin mucosal lesions distinguished condition canadianborn sir william osler johns hopkins hospital later oxford university made contributions report described characteristic lesions digestive english physician frederick parkes weber reported condition series term hereditary hemorrhagic telangiectasia first used american physician frederic hanes article diagnosis hht remained clinical one genetic defects cause hht identified research group duke university medical center international scientific advisory committee curehht formerly called hht foundation international published widely used curaÃ§ao group international experts met canada formulated evidencebased guideline sponsored guideline since updated found edar edar hypohidrotic ectodermal dysplasia httpsenwikipediaorgwikihereditaryhemorrhagictelangiectasia